FDA Inspection 1163636 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1318956

The FDA completed an inspection of American Red Cross Blood Services on February 28, 2022 in Rochester, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Rochester, NY (United States)